Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022 at 18:13 PM EDT
Kodiak Sciences Inc. (NASDAQ: KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.